Fiche publication
Date publication
juillet 2025
Journal
Annales pharmaceutiques francaises
Auteurs
Membres identifiés du Cancéropôle Est :
Dr COLIAT Pierre
Tous les auteurs :
Ranchon F, Slimano F, Borget I, Boulin M, Bardin C, Coliat P, Cormier N, Devys C, Fanciullino R, Paul M, Puisset F, Rioufol C, Tortolano L, Tournamille JF, Vigneron J, Chevrier R, Pourroy B, Cazin JL
Lien Pubmed
Résumé
The role of hospital oncology pharmacists (HOP) in the care of cancer patients has evolved considerably. This evidence led the experts of the French Society for Oncology Pharmacy (SFPO) to write a position paper. The first part presents the key insights of oncology pharmacy services (technology aspects of anticancer drug preparation and clinical pharmacy services), training of HOPs and research activities (clinical trials, research in oncology pharmacy). The second part of this position paper refers to the challenges and perspectives of E-health and artificial intelligence, precision medicine, access to innovation, and environmental issues.
Mots clés
document de position, oncology pharmacy, pharmacie oncologique, position paper
Référence
Ann Pharm Fr. 2025 07 10;:
